Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,018+, returning 12,482.3%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,482.34% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 4,581.69% |
DeFi Development (DFDV) | 2,234.67% |
WW International, Inc Common Stock (WW) | 1,887.79% |
Zepp Health (ZEPP) | 1,768.08% |
Abits (ABTS) | 1,208.78% |
Abivax SA American Depositary Shares (ABVX) | 1,195.17% |
Oncology Institute (TOI) | 1,138.56% |
FiEE (FIEE) | 1,129.36% |
Global Interactive Technologies (GITS) | 742.32% |
Nova Lifestyle I (NVFY) | 713.92% |
TMC the metals (TMC) | 679.39% |
Lizhi (SOGP) | 659.71% |
Nanobiotix (NBTX) | 658.84% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 644.64% |
M3-Brigade Acquisition V Corp Warrant (MBAVW) | 633.7% |
Airnet Technology (ANTE) | 627.88% |
Oklo (OKLO) | 593.17% |
United States Antimony (UAMY) | 585.96% |
Above Food Ingredients Inc Common Stock (ABVE) | 585.45% |
NioCorp Developments Ltd Common Stock (NB) | 553.46% |
Lucas GC Limited Ordinary Shares (LGCL) | 540.6% |
Dominari (DOMH) | 529.34% |
Better Home & Finance (BETR) | 521.41% |
